Deucravacitinib is an Orally Active TYK2 Allosteric Inhibitor for Autoimmune Diseases Research 2023-04-11 Edward Jenner Tyrosine kinase 2 (TYK2) is a member of the JAK kinase family. Besides, it regulates signal transduction downstream of the… Continue Reading →